Biogen Ups Stake In Targeted Genetics

Biogen Idec Inc. (BIIB) nearly doubled its stake in Targeted Genetics Corp. (TGEN) by converting much of its debt into shares of Targeted. Targeted stock leaped 75 cents to close at $2.90 while Biogen stock edged up 39 cents to close at $48.80.